DeCarbon and GN Innovation Partner to Develop Hydrogen from Medical Waste in South Korea
DeCarbon has partnered with GN Innovation to develop a business model for converting medical waste into hydrogen in South Korea. The collaboration will integrate sterilization, transport, and hydrogen production, utilizing DeCarbon's technology for high-purity hydrogen from waste plastics and GN Innovation's equipment for medical waste processing. A pilot test is planned for the first half of 2026 at a research complex in Incheon, with DeCarbon seeking regulatory support from the Ministry of Environment.
Theia Market Signal Identification - AI Assisted
DeCarbon has signed an MOU with GN Innovation to develop a business model for treating and recovering energy from medical waste. The partnership aims to integrate sterilisation, transport, and hydrogen production into a circular system.
DeCarbon's HR technology produces high-purity hydrogen by gasifying waste plastics. GN Innovation has equipment to sterilise and crush medical waste to meet general waste standards. The partnership will roll out projects for sterilisation and transport of medical waste from healthcare institutions, linking these to hydrogen production and power generation.
A pilot test will classify sterilised medical waste samples and install systems at a research complex in Seo-gu, Incheon, with trial operations set for the first half of 2026. DeCarbon has applied to the Ministry of Environment's regulatory sandbox to address regulatory challenges early.
Comments